» Articles » PMID: 19386095

Expression of Iron-related Genes in Human Brain and Brain Tumors

Overview
Journal BMC Neurosci
Publisher Biomed Central
Specialty Neurology
Date 2009 Apr 24
PMID 19386095
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Defective iron homeostasis may be involved in the development of some diseases within the central nervous system. Although the expression of genes involved in normal iron balance has been intensively studied in other tissues, little is known about their expression in the brain. We investigated the mRNA levels of hepcidin (HAMP), HFE, neogenin (NEO1), transferrin receptor 1 (TFRC), transferrin receptor 2 (TFR2), and hemojuvelin (HFE2) in normal human brain, brain tumors, and astrocytoma cell lines. The specimens included 5 normal brain tissue samples, 4 meningiomas, one medulloblastoma, 3 oligodendrocytic gliomas, 2 oligoastrocytic gliomas, 8 astrocytic gliomas, and 3 astrocytoma cell lines.

Results: Except for hemojuvelin, all genes studied had detectable levels of mRNA. In most tumor types, the pattern of gene expression was diverse. Notable findings include high expression of transferrin receptor 1 in the hippocampus and medulla oblongata compared to other brain regions, low expression of HFE in normal brain with elevated HFE expression in meningiomas, and absence of hepcidin mRNA in astrocytoma cell lines despite expression in normal brain and tumor specimens.

Conclusion: These results indicate that several iron-related genes are expressed in normal brain, and that their expression may be dysregulated in brain tumors.

Citing Articles

Ferritin as an Effective Prognostic Factor and Potential Cancer Biomarker.

Szymulewska-Konopko K, Reszec-Gielazyn J, Maleczek M Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852175 PMC: 11763953. DOI: 10.3390/cimb47010060.


Guanylate cyclase promotes osseointegration by inhibiting oxidative stress and inflammation in aged rats with iron overload.

Tao Z, Shen C Bone Joint Res. 2024; 13(9):427-440.

PMID: 39216851 PMC: 11365736. DOI: 10.1302/2046-3758.139.BJR-2023-0396.R3.


Changes of Target Essential Trace Elements in Multiple Sclerosis: A Systematic Review and Meta-Analysis.

Stojsavljevic A, Jagodic J, Perovic T, Manojlovic D, Pavlovic S Biomedicines. 2024; 12(7).

PMID: 39062163 PMC: 11274787. DOI: 10.3390/biomedicines12071589.


Iron chelators: as therapeutic agents in diseases.

Salimi Z, Afsharinasab M, Rostami M, Eshaghi Milasi Y, Mousavi Ezmareh S, Sakhaei F Ann Med Surg (Lond). 2024; 86(5):2759-2776.

PMID: 38694398 PMC: 11060230. DOI: 10.1097/MS9.0000000000001717.


Expression of antimicrobial host defence peptides in the central nervous system during health and disease.

Smith K, Gwyer Findlay E Discov Immunol. 2024; 1(1):kyac003.

PMID: 38566904 PMC: 10917193. DOI: 10.1093/discim/kyac003.


References
1.
Wang X, Lee S, Simmons Z, Boyer P, Scott K, Liu W . Increased incidence of the Hfe mutation in amyotrophic lateral sclerosis and related cellular consequences. J Neurol Sci. 2004; 227(1):27-33. DOI: 10.1016/j.jns.2004.08.003. View

2.
Peyssonnaux C, Zinkernagel A, Schuepbach R, Rankin E, Vaulont S, Haase V . Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest. 2007; 117(7):1926-32. PMC: 1884690. DOI: 10.1172/JCI31370. View

3.
Park C, Valore E, Waring A, Ganz T . Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem. 2000; 276(11):7806-10. DOI: 10.1074/jbc.M008922200. View

4.
Schofield C, Ratcliffe P . Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 2004; 5(5):343-54. DOI: 10.1038/nrm1366. View

5.
Guerreiro R, Bras J, Santana I, Januario C, Santiago B, Morgadinho A . Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort. BMC Neurol. 2006; 6:24. PMC: 1534050. DOI: 10.1186/1471-2377-6-24. View